Demethylation of TNFSF7 contributes to CD70 overexpression in CD4+ T cells from patients with systemic sclerosis

Clinical Immunology

Volumn 143, Issue 1, 2012, Pages 39-44

  Jiang, HongYan ^a   Xiao, Rong ^a   Lian, XiaoRi ^a   Kanekura, Takuro ^c   Luo, YangYang ^a   Yin, YongXing ^a   Zhang, GuiYing ^a   Yang, Yan ^a   Wang, YaoYao ^a   Zhao, Ming ^a,b   Lu, QianJin ^a,b  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b Hunan Key Laboratory of Medical Epigenomics   (China)

^c KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

CD4+ T cells; CD70; DNA methylation; Systemic sclerosis

Indexed keywords

CD70 ANTIGEN; CELL PROTEIN; PROTEIN TNFSF7; UNCLASSIFIED DRUG;

ADULT; ANTIGEN EXPRESSION; ARTICLE; AUTOIMMUNITY; CD4+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; DEMETHYLATION; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IMMUNOPATHOGENESIS; MALE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN METHYLATION; SYSTEMIC SCLEROSIS;

ADULT; ANTIGENS, CD70; CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; DNA METHYLATION; FEMALE; GENE EXPRESSION REGULATION; HUMANS; MALE; MIDDLE AGED; PROMOTER REGIONS, GENETIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SCLERODERMA, SYSTEMIC; YOUNG ADULT;

EID: 84862777126     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2012.01.005     Document Type: Article

References (23)

1. Badea I., Taylor M., Rosenberg A., Foldvari M. Pathogenesis and therapeutic approaches for improved topical treatment in localized scleroderma and systemic sclerosis. Rheumatology 2009, 48:213-221.
2. Abraham D.J., Krieg T., Distler J., Distler O. Overview of pathogenesis of systemic sclerosis. Rheumatology (Oxford) 2009, 48:iii3-iii7.
3. Denton C.P., Black C.M., Abraham D.J. Mechanisms and consequences of fibrosis in systemic sclerosis. Nat. Rev. Rheumatol. 2006, 2:134-144.
4. Sakkas L.I., Chikanza I.C., Platsoucas C.D. Mechanisms of disease: the role of immune cells in the pathogenesis of systemic sclerosis. Nat. Rev. Rheumatol. 2006, 2:679-685.
5. Agematsu K., Kobata T., Yang F., Nakazawa T., Fukushima K., Kitahara M., et al. CD27/CD70 interaction directly drives B cell IgG and IgM synthesis. Eur. J. Immunol. 1995, 25:2825-2829.
6. Jacquot S. CD27/CD70 interactions regulate T dependent B cell differentiation. Immunol. Res. 2000, 21:23-30.
7. Arens R.A., Nolte M.A., Tesselaar K., Heemskerk B., Reedquist K.A., Liter R.A., et al. Signaling through CD70 regulates B cell activation and IgG production. J. Immunol. 2004, 173:3901-3908.
8. Yang F., Agematsu K., Nakazawa T., Mori T., Ito S., Kobata T., et al. CD27/CD70 interaction directly induces natural killer cell killing activity. Immunology 1996, 88:289-293.
9. Lu Q., Wu A., Richardson B.C. Demethylation of the same promoter sequence increases CD70 expression in lupus T cells and T cells treated with lupus-inducing drugs. J. Immunol. 2005, 174:6212-6219.
10. Yin H., Zhao M., Wu X., Gao F., Luo Y., Le M., et al. Hypomethylation and overexpression of CD70 (TNFSF7) in CD4+ T cells of patients with primary Sjögren's syndrome. J. Dermatol. Sci. 2010, 59:198-203.
11. Luo Y., Zhao M., Lu Q. Demethylation of promoter regulatory elements contributes to CD70 overexpression in CD4+ T cells from patients with subacute cutaneous lupus erythematosus. Clin. Exp. Dermatol. 2010, 35:425-430.
12. Lonzetti L.S., Joyal F., Raynauld J.P., Roussin A., Goulet J.R., Rich E., et al. Updating the American College of Rheumatology preliminary classification criteria for systemic sclerosis: addition of severe nailfold capillaroscopy abnormalities markedly increases the sensitivity for limited scleroderma. Arthritis Rheum. 2001, 44:735-736.
13. Aggarwal B.B. Signalling pathways of the TNF superfamily: a double-edged sword. Nat. Rev. Immunol. 2003, 3:745-756.
14. Boursalian T.E., McEarchern J.A., Law C.L., Grewal I.S. Targeting CD70 for human therapeutic use. Adv. Exp. Med. Biol. 2009, 647:108-119.
15. Oelke K., Lu Q., Richardson D., Wu A., Deng C., Hanash S., et al. Overexpression of CD70 and overstimulation of IgG synthesis by lupus T cells and T cells treated with DNA methylation inhibitors. Arthritis Rheum. 2004, 50:1850-1860.
16. Lee W.W., Yang Z.Z., Li G., Weyand C.M., Goronzy J.J. Unchecked CD70 expression on T cells lowers threshold for T cell activation in rheumatoid arthritis. J. Immunol. 2007, 179:2609-2615.
17. Oflazoglu E., Boursalian T.E., Zeng W., Edwards A.C., Duniho S., McEarchen J.A., et al. Blocking of CD27-CD70 pathway by anti-CD70 antibody ameliorates joint disease in murine collagen-induced arthritis. J. Immunol. 2009, 183:3770-3777.
18. Nakajima A., Oshima H., Nohara C., Morimoto S., Yoshino S., Kobata T., et al. Involvement of CD70-CD27 interactions in the induction of experimental autoimmune encephalomyelitis. J. Neuroimmunol. 2000, 109:188-196.
19. Sawalha A.H., Richardson B. DNA methylation in the pathogenesis of systemic lupus erythematosus. Curr. Pharmacogenomics 2005, 3:73-78.
20. Attwood J.T., Yung R.L., Richardson B.C. DNA methylation and the regulation of gene transcription. Cell. Mol. Life Sci. 2002, 59:241-257.
21. Li Y., Sawalha A.H., Lu Q. Aberrant DNA methylation in skin diseases. J. Dermatol. Sci. 2009, 54:143-149.
22. Lei W., Luo Y., Yan K., Zhao S., Li Y., Qiu X., et al. Abnormal DNA methylation in CD4+ T cells from patients with systemic lupus erythematosus, systemic sclerosis, and dermatomyositis. Scand. J. Rheumatol. 2009, 38:369-374.
23. Sawalha A.H., Jeffries M. Defective DNA methylation and CD70 overexpression in CD4+ T cells in MRL/lpr lupus-prone mice. Eur. J. Immunol. 2007, 37:1407-1413.